These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34345035)

  • 1. AI drug discovery booms in China.
    Cyranoski D
    Nat Biotechnol; 2021 Aug; 39(8):900-902. PubMed ID: 34345035
    [No Abstract]   [Full Text] [Related]  

  • 2. Partners in discovery.
    Fuyuno I
    Nature; 2018 Mar; 555(7697):S60. PubMed ID: 29565400
    [No Abstract]   [Full Text] [Related]  

  • 3. RuiPing Dong. Interview by Asher Mullard.
    Dong R
    Nat Rev Drug Discov; 2012 Feb; 11(2):100. PubMed ID: 22293559
    [No Abstract]   [Full Text] [Related]  

  • 4. Are academic drug discovery efforts receiving more recognition with declining industry efficiency?
    Bryans JS; Kettleborough CA; Solari R
    Expert Opin Drug Discov; 2019 Jul; 14(7):605-607. PubMed ID: 30907161
    [No Abstract]   [Full Text] [Related]  

  • 5. Bringing together the academic drug discovery community.
    Slusher BS; Conn PJ; Frye S; Glicksman M; Arkin M
    Nat Rev Drug Discov; 2013 Nov; 12(11):811-2. PubMed ID: 24172316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deal watch: Valuation benefits of structure-enabled drug discovery.
    Borshell N; Papp T; Congreve M
    Nat Rev Drug Discov; 2011 Mar; 10(3):166. PubMed ID: 21358725
    [No Abstract]   [Full Text] [Related]  

  • 7. Evolving models of collaborative drug discovery: managing intellectual capital assets.
    Allarakhia M
    Expert Opin Drug Discov; 2018 Jun; 13(6):473-476. PubMed ID: 29569503
    [No Abstract]   [Full Text] [Related]  

  • 8. Large drug firms narrow their therapeutic interests.
    Mullard A
    Lancet; 2014 May; 383(9932):1873. PubMed ID: 24892171
    [No Abstract]   [Full Text] [Related]  

  • 9. Combating the cons of consolidation.
    Nat Rev Drug Discov; 2009 Mar; 8(3):177. PubMed ID: 19263592
    [No Abstract]   [Full Text] [Related]  

  • 10. Vertical disintegration: a strategy for pharmaceutical businesses in 2009?
    Dixon J; Lawton G; Machin P
    Nat Rev Drug Discov; 2009 Jun; 8(6):435. PubMed ID: 19483701
    [No Abstract]   [Full Text] [Related]  

  • 11. Pfizer's home remedy.
    Abkowitz A
    Fortune; 2009 Aug; 160(4):82-4, 86. PubMed ID: 19728588
    [No Abstract]   [Full Text] [Related]  

  • 12. Future pharmaceutical research: the need to look beyond science.
    Seeger S
    Future Med Chem; 2014 May; 6(7):721-3. PubMed ID: 24941866
    [No Abstract]   [Full Text] [Related]  

  • 13. Biopharma CRO industry in China: landscape and opportunities.
    Xia C; Gautam A
    Drug Discov Today; 2015 Jul; 20(7):794-8. PubMed ID: 25701282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in R&D openness to tackle disease in the developing world.
    Parks L
    Future Med Chem; 2012 Dec; 4(18):2237. PubMed ID: 23234547
    [No Abstract]   [Full Text] [Related]  

  • 15. Matchmaking service links up researchers to wallflower drugs.
    Schubert C
    Nat Med; 2010 Jan; 16(1):7. PubMed ID: 20057395
    [No Abstract]   [Full Text] [Related]  

  • 16. Digitizing the Pharma Neurons - A Technological Operation in Progress!
    Bhardwaj P; Yadav RK; Kurian S
    Rev Recent Clin Trials; 2020; 15(3):178-187. PubMed ID: 32564760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contract Research Organizations (CROs) in China: integrating Chinese research and development capabilities for global drug innovation.
    Shi YZ; Hu H; Wang C
    Global Health; 2014 Nov; 10():78. PubMed ID: 25406839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial intelligence in drug development: present status and future prospects.
    Mak KK; Pichika MR
    Drug Discov Today; 2019 Mar; 24(3):773-780. PubMed ID: 30472429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug discovery: new models for industry-academic partnerships.
    Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
    Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Medicines Company: an emerging pharmaceutical company in cardiology is spearheading an innovative approach to critical care medicines.
    Mayor S
    Eur Heart J; 2009 Jul; 30(13):1541-3. PubMed ID: 19579293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.